Nationwide implementation of antibiotic management teams in Belgian hospitals: A self-reporting survey

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 576-580

  van Gastel, Evelyne ^a   Costers, Michiel ^a   Peetermans, Willy E ^b   Struelens, Marc J ^c  

^a Belgian Antibiotic Policy Coordinating Committee   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

Antibiotic resistance; Antimicrobial stewardship; Antimicrobials

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; LINEZOLID; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BELGIUM; DRUG BIOAVAILABILITY; DRUG USE; HEALTH CARE PLANNING; HEALTH SURVEY; HOSPITAL; HOSPITAL MANAGEMENT; HOSPITAL POLICY; PRESCRIPTION; QUESTIONNAIRE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BELGIUM; DRUG UTILIZATION; HEALTH POLICY; HEALTH SERVICES RESEARCH; HOSPITALS; HUMANS; QUESTIONNAIRES;

EID: 77950303985     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp470     Document Type: Article

References (29)

1. Dellit T, Owens R, McGowen J et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
2. MacDougall C, Polk R. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005; 18: 638-56.
3. Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis 2008; 21: 344-9.
4. Owens RC Jr. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis 2008; 61: 110-28.
5. Sourdeau L, Struelens MJ, Peetermans WE et al. Implementation of antibiotic management teams in Belgian hospitals. Acta Clin Belg 2006; 6: 58-63.
6. Struelens MJ, Costers M. Hospital antibiotic management in Belgium, results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr 2008, 120: 284-8.
7. Struelens MJ, Peetermans WE. The antimicrobial resistance crisis in hospitals calls for multidisciplinary mobilization. Acta Clin Belg 1999: 54:2-6.
8. Pope SD, Dellit TH, Owens RC et al. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 2009; 30:97-8.
9. Nault V, Beaudoin M, Thirion DJG et al. Antimicrobial stewardship in acute care centres: a survey of 68 hospitals in Quebec. Can J Infect Dis Med Microbiol 2008; 19: 237-42.
10. Fraser GL, Stogsdill P, Dickens JD Jr et al. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997; 157: 1689-94.
11. Gums JG, Yancey RW Jr, Hamilton CA et al. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999; 19: 1369-77.
12. Solomon DH, Van Houten L, Glynn RJ et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001; 161: 1897-902.
13. Carling P, Fung T, Killion A et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24: 699-706.
14. LaRocco A Jr. Concurrent antibiotic review programs - a role for infectious diseases specialists at small community hospitals. Clin Infect Dis 2003; 37: 742-3.
15. Maswoswe JJ, Okpara AU. Enforcing a policy for restricting antimicrobial drug use. Am J Health Syst Pharm 1995; 52: 1433-5.
16. White AC Jr, Atmar RL, Wilson J et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25: 230-9.
17. Rahal JJ, Urban C, Horn D et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 1233-7.
18. Bamberger DM, Dahl SL. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch Intern Med 1992; 152: 554-7.
19. Lautenbach E, LaRosa LA, Marr AM et al. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary restrictions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003; 36: 440-6.
20. Price J, Ekleberry A, Grover A et al. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit Care Med 1999; 27: 2118-24.
21. Ibrahim EH, Ward S, Sherman G et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29: 1109-15.
22. South M, Royle J, Starr M. A simple intervention to improve hospital antibiotic prescribing. Med J Aust 2003; 178: 207-9.
23. Briceland LL, Nightingale CH, Quintiliani R et al. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med 1998; 148: 2019-22.
24. Glowacki RC, Schwartz DN, Itokazu GS et al. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiologyand pilot intervention of computer-assisted surveillance. Clin Infect Dis 2003; 37: 59-64.
25. Micek ST, Ward S, Fraser VJ et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125: 1791-9.
26. Przybyiski KG, Rybak MJ, Martin PR et al. A pharmacist-initiated program of intravenous to oral antibiotic conversion. Pharmacotherapy 1997; 17: 271-6.
27. Al-Eidan FA, McElnay JC, Scott MG et al. Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children. J Antimicrob Chemother 1999; 44: 709-15.
28. Siegel RE, Halpern NA, Almenoff PL et al. A prospective randomized study of inpatient iv antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest 1996; 110: 965-71.
29. Li JZ, Willke RJ, Rittenhouse BE et al. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial. Surg Infect (Larchmt) 2003; 4: 57-70.